Difference between revisions of "Vitronectin (TG2)"
Line 8: | Line 8: | ||
|- | |- | ||
| Synonyms | | Synonyms | ||
− | | - | + | | Serum-spreading factor |
|- | |- | ||
| Determination type | | Determination type | ||
− | | In | + | | In vitro |
|- | |- | ||
| Source | | Source | ||
Line 29: | Line 29: | ||
|- | |- | ||
| Substrate sequence | | Substrate sequence | ||
− | | | + | | KGNPE''Q''TPVLK |
|- | |- | ||
| Structure | | Structure |
Revision as of 06:58, 24 July 2007
Template:Infobox header| Vitronectin (TG2) | |
---|---|
Vitronectin (TG2) | |
Substrate peptide name | Vitronectin (TG2) |
Synonyms | Serum-spreading factor |
Determination type | In vitro |
Source | Homo sapiens |
Subcellular localization | Cytoskeleton |
Swissprot ID | P04004 |
Reactive glutamines | Q93* |
Reactive lysines | - |
Substrate sequence | KGNPEQTPVLK |
Structure | 1OC0 |
Surface accessibility | ASAView pdf |
Disorder prediction | IUPred |
Reference | PMID:2461707 |
Notes | *Reactive Q residues have been determined only for FXIIIa catalyzis; probably TG2 uses the same Q residues as substrates |
Template:Infobox header | |